- Home
- PYPD vs FAT Comparison
PYPD vs FAT Comparison
Compare PYPD & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- FAT
- Stock Information
- Founded
- PYPD 2008
- FAT 2017
- Country
- PYPD Israel
- FAT United States
- Employees
- PYPD N/A
- FAT N/A
- Industry
- PYPD Medical/Dental Instruments
- FAT Restaurants
- Sector
- PYPD Health Care
- FAT Consumer Discretionary
- Exchange
- PYPD Nasdaq
- FAT Nasdaq
- Market Cap
- PYPD 34.8M
- FAT 35.6M
- IPO Year
- PYPD 2020
- FAT 2017
- Fundamental
- Price
- PYPD N/A
- FAT $2.08
- Analyst Decision
- PYPD Strong Buy
- FAT Strong Buy
- Analyst Count
- PYPD 5
- FAT 1
- Target Price
- PYPD $12.00
- FAT $10.00
- AVG Volume (30 Days)
- PYPD 49.5K
- FAT 65.6K
- Earning Date
- PYPD 11-12-2025
- FAT 10-29-2025
- Dividend Yield
- PYPD N/A
- FAT 6.73%
- EPS Growth
- PYPD N/A
- FAT N/A
- EPS
- PYPD N/A
- FAT N/A
- Revenue
- PYPD N/A
- FAT $577,500,000.00
- Revenue This Year
- PYPD N/A
- FAT N/A
- Revenue Next Year
- PYPD N/A
- FAT $7.74
- P/E Ratio
- PYPD N/A
- FAT N/A
- Revenue Growth
- PYPD N/A
- FAT 0.96
- 52 Week Low
- PYPD $2.30
- FAT $1.75
- 52 Week High
- PYPD $3.93
- FAT $4.10
- Technical
- Relative Strength Index (RSI)
- PYPD 45.84
- FAT 55.00
- Support Level
- PYPD $3.34
- FAT $1.86
- Resistance Level
- PYPD $3.57
- FAT $2.03
- Average True Range (ATR)
- PYPD 0.13
- FAT 0.14
- MACD
- PYPD -0.00
- FAT 0.01
- Stochastic Oscillator
- PYPD 31.25
- FAT 43.00
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About FAT FAT Brands Inc.
FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.